Correlation Between Invesco Dynamic and IShares Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Invesco Dynamic and IShares Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invesco Dynamic and IShares Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invesco Dynamic Pharmaceuticals and iShares Pharmaceuticals ETF, you can compare the effects of market volatilities on Invesco Dynamic and IShares Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invesco Dynamic with a short position of IShares Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invesco Dynamic and IShares Pharmaceuticals.

Diversification Opportunities for Invesco Dynamic and IShares Pharmaceuticals

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Invesco and IShares is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Invesco Dynamic Pharmaceutical and iShares Pharmaceuticals ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Pharmaceuticals and Invesco Dynamic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invesco Dynamic Pharmaceuticals are associated (or correlated) with IShares Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Pharmaceuticals has no effect on the direction of Invesco Dynamic i.e., Invesco Dynamic and IShares Pharmaceuticals go up and down completely randomly.

Pair Corralation between Invesco Dynamic and IShares Pharmaceuticals

Considering the 90-day investment horizon Invesco Dynamic Pharmaceuticals is expected to generate 0.88 times more return on investment than IShares Pharmaceuticals. However, Invesco Dynamic Pharmaceuticals is 1.14 times less risky than IShares Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. iShares Pharmaceuticals ETF is currently generating about 0.05 per unit of risk. If you would invest  8,316  in Invesco Dynamic Pharmaceuticals on October 23, 2024 and sell it today you would earn a total of  86.00  from holding Invesco Dynamic Pharmaceuticals or generate 1.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Invesco Dynamic Pharmaceutical  vs.  iShares Pharmaceuticals ETF

 Performance 
       Timeline  
Invesco Dynamic Phar 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Dynamic Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward-looking indicators, Invesco Dynamic is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
iShares Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Pharmaceuticals ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Invesco Dynamic and IShares Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Invesco Dynamic and IShares Pharmaceuticals

The main advantage of trading using opposite Invesco Dynamic and IShares Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invesco Dynamic position performs unexpectedly, IShares Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Pharmaceuticals will offset losses from the drop in IShares Pharmaceuticals' long position.
The idea behind Invesco Dynamic Pharmaceuticals and iShares Pharmaceuticals ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamental Analysis
View fundamental data based on most recent published financial statements